View Entire Collection
By Clinical Topic
By State Requirement
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
THURSDAY, April 7 (HealthDay News) -- New guidelines for the treatment of children with juvenile idiopathic arthritis (JIA) have been developed by the American College of Rheumatology; the guidelines are based on the best available scientific evidence and expert opinion and have been published in the April issue of Arthritis Care & Research.
Timothy Beukelman, M.D., of the University of Alabama at Birmingham, and colleagues reviewed more than 200 JIA-related studies and evaluated more than 1,500 clinical scenarios to develop guidelines for initiating and monitoring treatment of the condition.
To streamline treatment, the guidelines identify five different JIA treatment groups based on disease characteristics. The guidelines address the use of multiple drugs, including nonsteroidal anti-inflammatory drugs, intraarticular glucocorticoid injections, non-biologic disease-modifying antirheumatic drugs, biologic disease-modifying antirheumatic drugs, and systemic glucocorticoids.
"Guidelines and recommendations are intended to promote beneficial or desirable outcomes but cannot guarantee any specific outcome. Guidelines and recommendations developed or endorsed by the American College of Rheumatology are subject to periodic revision as warranted by the evolution of medical knowledge, technology, and practice," the authors write.
Several authors disclosed financial relationships with pharmaceutical companies.
Full Text (subscription or payment may be required)
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top